News

Oxidized low-density lipoprotein (oxidized LDL) is an established biomarker for oxidative stress and a specific causal biomarker for the atherosclerotic disease process. Elevated plasma levels of oxid...

Mercodia offers products and services with well-defined quality and high precision of delivery which places the utmost importance on our Quality Department and the role they play within Mercodia. Meet...

Mercodia Assay Quality System, MAQS, is a 69-point program developed to explore and explain the unrivaled quality of our products and is the first certification of its kind. Your research projects and...

In this interview Professor Rémy Burcelin, Head of Research Inserm, tells his story about the search for sensitive insulin, glucagon and GLP-1 markers. Prof. Rémy Burcelin and his team aims at identif...

Jörgen Dahlström joined Mercodia as new CEO as of the 1st of October of 2021. We spoke to him about his background in life science, but more importantly about his desire to drive Mercodia forward. Jör...

We are glad to present another Mercodia customer in our interview series. Please meet InSphero! InSphero is a Swiss-based biotech company that has been perfecting 3D cell-based drug discovery platform...

Welcome to a new Mercodia Webinar where Professor Fredrik Bäckhed from Gothenburg University will discuss the influence of the gut microbiota in type 2 diabetes. We are proud to present Professor Fred...

The Mercodia Glucagon ELISA was chosen for the glucagon measurements in the Restoring Insulin Secretion (RISE) study. Here we present data from the evaluation of our assay, and conclusions drawn from ...

We are happy to present a new Mercodia customer in our interview series. Please meet Dr. Hanne Scholz at Oslo University Hospital. Dr. Hanne Scholz is the Director of the&nbsp...